R 396

CAS No. 129809-09-2

R 396( Acleu-asp-gln-trp-phe-glynh2 )

Catalog No. M27790 CAS No. 129809-09-2

R 396 is a linear hexapeptide and is also an NK-2 tachykinin receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 795 Get Quote
10MG 1193 Get Quote
25MG 2067 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    R 396
  • Note
    Research use only, not for human use.
  • Brief Description
    R 396 is a linear hexapeptide and is also an NK-2 tachykinin receptor antagonist.
  • Description
    R 396 is a linear hexapeptide and is also an NK-2 tachykinin receptor antagonist.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Acleu-asp-gln-trp-phe-glynh2
  • Pathway
    GPCR/G Protein
  • Target
    Neurokinin Receptor
  • Recptor
    Cereblon
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    129809-09-2
  • Formula Weight
    805.89
  • Molecular Formula
    C39H51N9O10
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(N)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shaomeng Wang, et al. Monofunctional intermediates for ligand-dependent target protein degradation. WO2017176958A1
molnova catalog
related products
  • Senktide

    Senktide is an?agonist of tachykinin NK3 receptor.

  • QWF

    Tripeptide substance P (SP) antagonist (IC50 = 90 μM). Also inhibits binding of SP to Mas-related GPCR (MRGPR) X2. Inhibits SP-induced IgE-independent degranulation of mast cells in vitro. Inhibits compound 48/80-induced MRGPRX2 activation and scratching in mice in vivo.

  • Rolapitant hydrochlo...

    Rolapitant (SCH619734) hydrochloride is a potent, selective, long-acting, and orally active neurokinin 1 (NK1) receptor antagonist with a K_i of 0.66 nM, which does not interact with CYP3A4 and demonstrates potent centrally-mediated anti-emetic activity in both acute and delayed ferret emesis models .